AUTL Autolus Therapeutics plc - American Depositary Shares
$2.47
价格 · 八月 20, 2026
截至...的财报数据 八月 11, 2026
52周区间
$1–$3
92% of range
分析师评级
BUY
16 analysts
目标价
$9
+253% upside
P/E (TTM)
-1.8
ROE
-109.6%
净利润率
-381.4%
AUTL 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$2.47
市值
—
P/E (TTM)
-1.8
每股收益 (TTM)
$-1.08
营收 (TTM)
$75M
股息收益率
—
ROE
-109.6%
负债/权益
—
52周区间
$1 – $3
AUTL 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$75M
2023-12-31
→
2025-12-31
EPS
$-1.08
2022-12-31
→
2025-12-31
自由现金流
$-303M
2023-12-31
→
2025-12-31
利润率
-381.4%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
AUTL
同行中位数
P/E (TTM)
-1.8
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
AUTL
同行中位数
Operating Margin (营业利润率)
-358.9%
—
Net Profit Margin (净利润率)
-381.4%
-328.5%
ROA
-41.9%
-37.9%
ROE
-109.6%
-82.2%
ROIC
-152.9%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
AUTL
同行中位数
Current Ratio (流动比率)
5.9
5.0
Quick Ratio (速动比率)
1.7
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
AUTL
同行中位数
Revenue YoY (营收同比增长)
644.9%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
AUTL
同行中位数
AUTL 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
16 位分析师
- 强烈买入 6 37.5%
- 买入 9 56.2%
- 持有 1 6.2%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
8 位分析师 · 2026-08-16
中位数
$9.50
平均值
$8.72
← 低于所有目标
$2.47
最低
$5.00
最高
$11.00
中位数目标
$9.50
+284.6%
平均目标
$8.72
+253.3%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.01%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.15 | $-0.22 | 0.07% |
| 2026年3月31日 | $-0.27 | $-0.26 | -0.01% |
| 2025年12月31日 | $-0.34 | $-0.27 | -0.07% |
| 2025年9月30日 | $-0.30 | $-0.23 | -0.07% |
| 2025年6月30日 | $-0.18 | $-0.24 | 0.06% |
| 2025年3月31日 | $-0.26 | $-0.26 | -0.01% |
| 2024年12月31日 | $-0.10 | $-0.21 | 0.11% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| AUTL | — | -1.8 | 644.9% | -381.4% | -109.6% | — |
| CMPS | $663M | -2.2 | — | — | -524.8% | — |
| IMCR | $1.76B | -48.9 | 28.9% | -8.9% | -9.2% | — |
| BCYC | $491M | -2.2 | 105.8% | -301.7% | -34.2% | — |
| TLSA | — | — | — | — | — | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 16
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $75M | $10M | $2M | |
| Cost of Revenue | $96M | $11M | $0 | |
| R&D Expense | $118M | $138M | $130M | |
| SG&A Expense | $132M | $102M | $47M | |
| Operating Income | $-271M | $-241M | $-180M | |
| Interest Expense | $37M | $9M | $45M | |
| Interest Income | $19M | $32M | $14M | |
| Other Non-op | $515.0K | $220.0K | $222.0K | |
| Pretax Income | $-286M | $-219M | $-208M | |
| Income Tax | $2M | $2M | $-19.0K | |
| Net Income | $-288M | $-221M | $-208M | |
| EPS (Basic) | $-1.08 | $-0.86 | $-1.20 | |
| EPS (Diluted) | $-1.08 | $-0.86 | $-1.20 | |
| Shares (Basic) | 266,138,224 | 255,161,038 | 173,941,926 | |
| Shares (Diluted) | 266,138,224 | 255,161,038 | 173,941,926 | |
| EBITDA | $-262M | $-234M | $-173M |
资产负债表 21
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $104M | $227M | $240M | |
| Receivables | $24M | $15.0K | $109.0K | |
| Inventory | $33M | $4M | $0 | |
| Prepaid Expense | $76M | $67M | $35M | |
| Other Current Assets | $0 | $2M | $0 | |
| Current Assets | $436M | $661M | $275M | |
| PP&E (Net) | $64M | $50M | $35M | |
| Accum. Depreciation | $44M | $35M | $29M | |
| Intangibles | $20M | $12M | $0 | |
| Total Assets | $589M | $783M | $375M | |
| Accounts Payable | $3M | $2M | $103.0K | |
| Accrued Liabilities | $56M | $52M | $40M | |
| Current Liabilities | $73M | $61M | $45M | |
| Capital Leases | $67M | $50M | $48M | |
| Other Non-current Liabilities | $477.0K | $426.0K | $357.0K | |
| Total Liabilities | $411M | $355M | $264M | |
| Paid-in Capital | $1.57B | $1.56B | $1.02B | |
| Retained Earnings | $-1.39B | $-1.10B | $-879M | |
| AOCI | $-5M | $-29M | $-29M | |
| Stockholders' Equity | $178M | $427M | $111M | |
| Liabilities + Equity | $589M | $783M | $375M |
现金流 15
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $8M | $8M | $7M | |
| Deferred Tax | $-631.0K | $-175.0K | $-987.0K | |
| Amort. of Intangibles | $2M | $162.0K | $0 | |
| Restructuring | $2M | · | · | |
| Other Non-cash | $-4M | $7M | $57M | |
| Operating Cash Flow | $-284M | $-206M | $-146M | |
| CapEx | $19M | $22M | $11M | |
| Investing Cash Flow | $158M | $-395M | $-11M | |
| Stock Issued | $0 | $550M | $0 | |
| Net Stock Activity | $0 | $550M | $0 | |
| Financing Cash Flow | $-4M | $590M | $-883.0K | |
| Net Change in Cash | $-123M | $-12M | $-142M | |
| Taxes Paid | $2M | $2M | $551.0K | |
| Free Cash Flow | $-303M | $-228M | $-157M | |
| Levered FCF | $-340M | $-238M | $-202M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -358.9% | -2385.6% | · | |
| Net Margin | -381.4% | -2180.5% | · | |
| Pretax Margin | -378.8% | -2165.4% | · | |
| EBITDA Margin | -347.9% | -2311.0% | · | |
| ROA | -41.9% | -38.1% | -53.3% | |
| ROE | -109.6% | -48.8% | -142.7% | |
| ROIC | -152.9% | -56.9% | -161.2% |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 5.9 | 10.9 | 6.2 | |
| Quick Ratio | 1.7 | 3.7 | 5.4 | |
| Interest Coverage | -7.4 | -26.0 | -4.0 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · | |
| Inventory Turnover | 5.2 | 5.5 | · | |
| Receivables Turnover | 6.3 | 163.2 | · |
增长率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 644.9% | 496.0% | · |
估值 (TTM) 4
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $75M | $10M | $2M | |
| Net Income TTM | $-288M | $-221M | $-208M | |
| P/E | -1.8 | -2.7 | -5.4 | |
| Earnings Yield | -54.3% | -36.6% | -18.6% |
损益表 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $46M | $26M | $24M | $21M | $21M | $9M | $29.0K | $0 | $0 | $10M | |
| Cost of Revenue | $20M | $25M | $25M | $29M | $24M | $18M | $11M | $0 | $0 | $0 | |
| R&D Expense | $28M | $21M | $36M | $28M | $27M | $27M | $31M | $40M | $37M | $31M | |
| SG&A Expense | $41M | $40M | $36M | $36M | $30M | $30M | $34M | $27M | $22M | $18M | |
| Operating Income | $-44M | $-60M | $-72M | $-72M | $-61M | $-65M | $-76M | $-68M | $-59M | $-39M | |
| Interest Expense | $-3M | $11M | $23M | $11M | $-7M | $10M | $-31M | $11M | $10M | $19M | |
| Interest Income | $2M | $2M | $3M | $4M | $5M | $6M | $7M | $8M | $10M | $7M | |
| Other Non-op | $181.0K | $100.0K | $167.0K | $84.0K | $135.0K | $129.0K | $410.0K | $54.0K | $56.0K | $-300.0K | |
| Pretax Income | $-39M | $-71M | $-92M | $-79M | $-48M | $-68M | $-26M | $-82M | $-58M | $-53M | |
| Income Tax | $465.0K | $863.0K | $-1M | $532.0K | $397.0K | $2M | $1M | $22.0K | $51.0K | $-8.0K | |
| Net Income | $-39M | $-72M | $-90M | $-79M | $-48M | $-70M | $-28M | $-82M | $-58M | $-53M | |
| EPS (Basic) | $-0.15 | $-0.27 | $-0.34 | $-0.30 | $-0.18 | $-0.26 | $-0.09 | $-0.31 | $-0.22 | $-0.24 | |
| EPS (Diluted) | $-0.15 | $-0.27 | $-0.34 | $-0.30 | $-0.18 | $-0.26 | $-0.09 | $-0.31 | $-0.22 | $-0.24 | |
| Shares (Basic) | 266,158,829 | 266,143,425 | -532,271,166 | 266,141,431 | 266,141,411 | 266,126,548 | -499,120,041 | 266,084,589 | 266,025,783 | 222,170,707 | |
| Shares (Diluted) | 266,158,829 | 266,143,425 | -532,271,166 | 266,141,431 | 266,141,411 | 266,126,548 | -499,120,041 | 266,084,589 | 266,025,783 | 222,170,707 | |
| EBITDA | $-44M | $-57M | · | $-72M | $-61M | $-63M | · | $-68M | $-59M | $-37M |
资产负债表 21
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $171M | $131M | $104M | $86M | $124M | $96M | $227M | $657M | $706M | $759M | |
| Receivables | $44M | $28M | $24M | · | · | · | $15.0K | $0 | $0 | $0 | |
| Inventory | $33M | $33M | $33M | $28M | $24M | $15M | $4M | · | · | · | |
| Prepaid Expense | $55M | $77M | $76M | $85M | $68M | $69M | $67M | $60M | $52M | $45M | |
| Other Current Assets | · | · | $0 | · | $0 | $2M | $2M | · | · | · | |
| Current Assets | $336M | $369M | $436M | $515M | $574M | $616M | $661M | $718M | $759M | $804M | |
| PP&E (Net) | $61M | $62M | $64M | $67M | $66M | $58M | $50M | $44M | $33M | $33M | |
| Accum. Depreciation | $48M | $46M | $44M | $43M | $42M | $38M | $35M | $35M | $32M | $30M | |
| Intangibles | $19M | $19M | $20M | $20M | $13M | $12M | $12M | · | · | · | |
| Total Assets | $493M | $527M | $589M | $662M | $721M | $746M | $783M | $827M | $854M | $901M | |
| Accounts Payable | $1M | $2M | $3M | $11M | $5M | $4M | $2M | $1M | $1M | $1M | |
| Accrued Liabilities | $49M | $47M | $56M | $52M | $51M | $50M | $52M | $47M | $36M | $38M | |
| Current Liabilities | $69M | $64M | $73M | $83M | $68M | $67M | $61M | $52M | $41M | $44M | |
| Capital Leases | $78M | $77M | $67M | $61M | $61M | $55M | $50M | $49M | $46M | $47M | |
| Other Non-current Liabilities | $474.0K | $477.0K | $477.0K | $472.0K | $477.0K | $444.0K | $426.0K | $447.0K | $415.0K | $409.0K | |
| Total Liabilities | $418M | $418M | $411M | $396M | $375M | $375M | $355M | $351M | $326M | $319M | |
| Paid-in Capital | $1.58B | $1.57B | $1.57B | $1.57B | $1.56B | $1.56B | $1.56B | $1.55B | $1.55B | $1.54B | |
| Retained Earnings | $-1.50B | $-1.46B | $-1.39B | $-1.30B | $-1.22B | $-1.17B | $-1.10B | $-1.07B | $-990M | $-931M | |
| AOCI | $-6M | $-7M | $-5M | $-5M | $862.0K | $-18M | $-29M | $-898.0K | $-28M | $-29M | |
| Stockholders' Equity | $75M | $109M | $178M | $265M | $346M | $371M | $427M | $477M | $528M | $582M | |
| Liabilities + Equity | $493M | $527M | $589M | $662M | $721M | $746M | $783M | $827M | $854M | $901M |
现金流 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Amort. of Intangibles | $500.0K | $490.0K | $433.0K | $500.0K | $300.0K | $285.0K | $162.0K | $0 | $0 | $0 | |
| Restructuring | $3M | $1M | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $4M | · | · | · | $-7M | · | · | · | $10M | |
| Operating Cash Flow | $-25M | $-65M | $-67M | $-68M | $-73M | $-76M | $-38M | $-77M | $-51M | $-41M | |
| CapEx | $913.0K | $3M | $-885.0K | $4M | $7M | $8M | $11M | $10M | $841.0K | $533.0K | |
| Investing Cash Flow | $68M | $96M | $87M | $36M | $96M | $-60M | $-384M | $-10M | $-841.0K | $-533.0K | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $550M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $550M | |
| Financing Cash Flow | $-2M | $-2M | $-2M | $-2M | $-768.0K | $0 | $30M | $185.0K | $-2M | $561M | |
| Net Change in Cash | $40M | $27M | $18M | $-38M | $28M | $-132M | $-430M | $-48M | $-53M | $519M | |
| Taxes Paid | $1M | $209.0K | $429.0K | $501.0K | $1M | $9.0K | $1M | $279.0K | $984.0K | $0 | |
| Free Cash Flow | · | $-68M | · | · | · | $-84M | · | · | · | $-41M | |
| Levered FCF | · | $-79M | · | · | · | $-94M | · | · | · | $-60M |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -96.0% | -227.0% | · | -337.9% | -292.6% | -726.3% | · | · | · | · | |
| Net Margin | -85.6% | -273.1% | · | -373.3% | -229.0% | -781.1% | · | · | · | · | |
| Pretax Margin | -84.6% | -269.8% | · | -370.8% | -227.1% | -756.4% | · | · | · | · | |
| EBITDA Margin | -96.0% | -218.6% | · | -337.9% | -292.6% | -704.2% | · | · | · | · | |
| ROA | -6.4% | -11.2% | · | -10.6% | -6.1% | -8.5% | · | -13.3% | -13.7% | -11.7% | |
| ROE | -18.6% | -29.8% | · | -21.3% | -11.0% | -14.7% | · | -25.0% | -22.1% | -18.1% | |
| ROIC | -59.3% | -55.4% | · | -27.2% | -17.8% | -18.2% | · | -14.2% | -11.2% | -6.7% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.8 | · | 6.2 | 8.4 | 9.2 | · | 13.7 | 18.5 | 18.3 | |
| Quick Ratio | 3.1 | 2.5 | · | 1.0 | 1.8 | 1.4 | · | 12.5 | 17.3 | 17.2 | |
| Interest Coverage | 16.4 | -5.3 | · | -6.8 | 9.0 | -6.4 | · | -6.4 | -5.8 | -2.0 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | 0.7 | 1.0 | · | 2.1 | 2.0 | 2.5 | · | · | · | · | |
| Receivables Turnover | 2.1 | 1.9 | · | · | · | · | · | · | · | · |
估值 (TTM) 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $114M | $77M | · | $51M | $30M | $19M | · | · | · | · | |
| Net Income TTM | $-238M | $-269M | · | $-279M | $-258M | $-263M | · | $-239M | $-202M | $-184M | |
| P/E | -1.8 | -1.4 | · | -1.6 | -2.4 | -1.5 | · | -3.5 | -3.6 | -6.4 | |
| Earnings Yield | -56.2% | -73.2% | · | -64.4% | -42.5% | -66.5% | · | -28.4% | -28.2% | -15.5% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 收入 | $75M | $10M | $2M | — | — |
| 营业利润率 % | -358.9% | -2385.6% | — | — | — |
| 净收入 | $-288M | $-221M | $-208M | — | — |
| 稀释后每股收益 (EPS) | $-1.08 | $-0.86 | $-1.20 | — | — |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 流动比率 | 5.9 | 10.9 | 6.2 | — | — |
| 速动比率 | 1.7 | 3.7 | 5.4 | — | — |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 自由现金流 | $-303M | $-228M | $-157M | — | — |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 87 家申报者 · $212.8M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 11 (0 与上一季度对比) | 10 (-3 与上一季度对比) | 25 (-2 与上一季度对比) | 22 (-3 与上一季度对比) | +17.7M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 9 位内幕人士 · 0 位高管 · 9 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Ryan Richardson | 董事 | 2026年6月29日 A | — | 0 | 0 | $0 |
| Elisabeth Leiderman | 董事 | 2026年6月29日 A | — | 0 | 0 | $0 |
| Madduri Ravin Rao | 董事 | 2026年6月29日 A | — | 0 | 0 | $0 |
| Robert Iannone | 董事 | 2026年6月29日 A | — | 0 | 0 | $0 |
| Robert Azelby | 董事 | 2026年6月29日 A | — | 0 | 0 | $0 |
| Linda Bain | 董事 | 2026年6月29日 A | — | 0 | 0 | $0 |
| Cynthia M Butitta | 董事 | 2026年6月29日 A | — | 0 | 0 | $0 |
| Michael W Bonney | 董事 | 2026年6月29日 A | — | 0 | 0 | $0 |
| William D Young | 董事 | 2026年6月29日 A | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Renata Kellnerova, AMALAR HOLDING s.r.o., PPF GROUP N.V., PPF BIOTECH B.V. ×4 申报 | 2024年10月25日 | — | 初始申报 | — | SEC |
| BXLS V – Autobahn L.P., Blackstone Life Sciences Associates V (CYM) L.L.C., Blackstone Clarus GP L.L.C., Blackstone Holdings I L.P., Blackstone Holdings I/II GP L.L.C., Blackstone Inc., Blackstone Group Management L.L.C., Stephen A. Schwarzman ×3 申报 | 2024年5月21日 | — | 初始申报 | — | SEC |
| BioNTech SE | 2024年2月21日 | — | 初始申报 | 董事会活动 | SEC |
| Arix Bioscience Plc, Arix Bioscience Holdings Limited ×3 申报 | 2021年2月17日 | — | 初始申报 | — | SEC |
| PETR KELLNER, PPF GROUP N.V., PPF CAPITAL PARTNERS FUND B.V. ×7 申报 | 2020年8月13日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 5 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BIB · ProShares Trust | 0.02% | 7414 NS | 2026年5月31日 | N-PORT |
| APIE · Trust for Professional Managers | 0.00% | 22753 NS | 2026年5月31日 | N-PORT |
| IBB · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | — | — | 2026年7月20日 | 每日 |
| QQQS · Invesco Exchange-Traded Fund Trus... | — | — | 2026年7月20日 | 每日 |